Senior insider sale
Interim CFO at DAMORA THERAPEUTICS, INC. — senior position signals high conviction
$193.1K
7.62K shares
What this filing means
FIRMANI LORI plans to sell 7.62K shares of DAMORA THERAPEUTICS, INC. valued at approximately $193.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/22/2026ACC: 0001970051-26-000017
Officer· Interim CFO
Since Aug 2024
7.62K
Shares to sell
$193.1K
Approx. market value
18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Option
CASH
1/3/2025
5KOption
CASH
10/9/2024
5.79KOption
CASH
10/9/2024
7.21KTotal acquired18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/3/2025 | Option CASH | 5K | — |
10/9/2024 | Option CASH | 5.79K | — |
10/9/2024 | Option CASH | 7.21K | — |
| Total | 18K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
7.62K
Market value
$193.1K
6/22/2026
Total
Units
7.62K
Value
$193.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/22/2026 | 7.62K | $193.1K | NASDAQ | Planned |
| Total | 7.62K | $193.1K | ||